Search results
Results from the WOW.Com Content Network
Reshma Kewalramani, is the president and chief executive officer of Vertex Pharmaceuticals, a biotechnology company based in Boston, Massachusetts, as of April 1, 2020. [1] [2] [3] She is the first female CEO of a large US biotech company. [2]
Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. ... encouraged by then-President Robert Beall, ...
Jeffrey Leiden is an American physician, scientist and businessman who is the executive chairman of Vertex Pharmaceuticals, a biotechnology company based in Boston, Massachusetts. [1] He was initially appointed to the board of directors of the company in 2009 and was CEO and president from February 2012 to March 2020. [2] [3]
Vertex Pharmaceuticals (NASDAQ: VRTX) Q2 2024 Earnings Call Aug 01, 2024, 4:30 p.m. ET. ... Reshma Kewalramani, Vertex's CEO, and president; Stuart Arbuckle, chief operating officer; and Charlie ...
Vertex Pharmaceuticals (NASDAQ: VRTX) Q3 2024 Earnings Call Nov 04, 2024, 4:30 p.m. ET. ... Vertex's CEO and president; Stuart Arbuckle, chief operating officer; and Charlie Wagner, chief ...
Vertex Pharmaceuticals (NAS: VRTX) carries $802.8 million of goodwill and other intangibles on its balance sheet. Sometimes goodwill, especially when it's excessive, can foreshadow problems down ...
[3] [4] She then joined Vertex Pharmaceuticals as the chief scientific officer before becoming the senior VP of research and development and ultimately serving as the president of Vertex Pharmaceuticals from 2000 to 2005. During her tenure, the drugs Avonex, Tysabri, and Telaprevir were developed. [5] [6]
He is Executive Vice President, Global Research and Chief Scientific Officer at Vertex Pharmaceuticals. [4] Prior to joining Vertex in 2014, he was at the Broad Institute of Harvard and MIT , [ 5 ] and was a Professor of Genetics and Medicine at Harvard Medical School , and in the Department of Biology at Massachusetts Institute of Technology.